The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Oct 2011 07:00

RNS Number : 5856Q
AorTech International PLC
21 October 2011
 



AorTech International plc (the "Company" or "AorTech")Directorate Change

AorTech International plc (AIM: AOR) the biomaterials and medical device development company, is pleased to announce the appointment of Bill Brown as non-executive director of the Company with immediate effect.

 

William Donald Brown, aged 48, has been advising and investing in small companies for over 20 years. Having qualified as a chartered accountant in 1986, he started a career in venture capital with INVESCO before moving to Baronsmead (which later became Ivory & Sime, Friends Ivory & Sime, then ISIS). In 1996 he launched the seminal AIM Trust, the first dedicated fund for the AIM market. Bill went on to become head of ISIS's small company investment teams based in Edinburgh and London before leaving to found Bluehone Investors LLP in 2005. Bill is a former Chairman of the London Stock Exchange's AIM Advisory Group.

 

AorTech also announces that Stuart Rollason, non-executive director of the Company has resigned from the Board with immediate effect. The Board expresses its gratitude to Stuart for his service to the Company and wishes him well in the future.

 

Frank Maguire, Chief Executive of the Company, commented: "I would like to extend my thanks on behalf of the Board to Stuart Rollason for his contribution during the company's restructuring phase in 2004 and 2005 and in the development of its business model thereafter. We wish him all the best in his future endeavours. Separately, we are delighted to welcome Bill to the board and believe his extensive experience of the UK public markets and growth companies will be invaluable to AorTech as we enter a new phase following the relocation of our operations from Australia to the US and seek to capitalise on the commercial opportunities that the move is expected to bring."

 

There is no further information to be disclosed in accordance with Schedule 2 paragraph (g) of the AIM Rules, save as set out below:

Bill is currently a director of the following companies:

 

Target Dealing Company Limited

WB (No.1) Limited

Bluehone General Partner (DCP) Limited

Bluehone Partner Limited

Bluehone Ventures Limited

Bluehone Ventures Nominees Limited

Bluehone Limited

Bluehone Holdings plc

Cambridge Sensors Limited

 

Bill is also currently a partner of Bluehone Investors LLP which manages the investment portfolio of Active Capital Trust plc, which in turn holds 891,861 ordinary shares in the Company, representing 18.45 per cent. of the current issued share capital of the Company.

 

Bill has, in the last 5 years, been a director of the following companies:

 

Impax Environmental Markets plc

Landround plc

 

21 October 2011

 

For further information contact:

 

AorTech International plc 

Frank Maguire, Chief Executive Tel: + 1 801 201 4336 

 

AorTech International plc 

Sarah Price, Media Relations Tel: + 1 801 550 4349 

e-mail: sprice@aortech.com 

 

Evolution Securities Limited

Chris Clarke Tel: +44 20 7071 4300 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFBLLLFBFFFBE
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.